Table 4.
HBB disorder | Genotype | Phenotype | % HbA |
---|---|---|---|
β-thalassemia minor | ββ0, ββ+ (i.e., carriers) | Asymptomatic or mild microcytic hypochromic anemia may be present. | 92–95% |
β-thalassemia intermedia | β+β+, β+β0 (typically with alpha gene deletion) | Later onset, microcytic hypochromic anemia, jaundice, hepatosplenomegaly, risk of iron overload. | 10–30% |
β-thalassemia major | β0β0, β+β+, β+β0 | Onset within 2 years of life, severe microcytic hypochromic anemia, hepatosplenomegaly, failure to thrive. | 0% |
Sickle cell disease | HbS/HbS [homozygous for c.20A>T (p.Glu7Val)] | Onset in infancy, severe anemia, splenomegaly, jaundice, episodes of severe pain including swelling of hands and feet, stroke in childhood | Low to absent |
β, wildtype HBB locus; β0, pathogenic variant resulting in no production of HBB protein (e.g., deletion); β+, pathogenic variant resulting in reduced production of HBB protein (e.g., promoter variant).